|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold and other short term investments | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Held to maturity securities ($3,867 and $4,389 fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Federal Home Loan Bank stock | ||||||||||||||||||||
| Loans, net of deferred costs | ||||||||||||||||||||
| Less: Allowance for credit losses on loans | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Demand | ||||||||||||||||||||
| Interest-bearing checking | ||||||||||||||||||||
| Savings accounts | ||||||||||||||||||||
| Money market deposit accounts | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Capital stock par value $1.00; 30,000,000 shares authorized; 20,118,509 shares issued at both June 30, 2026 and December 31, 2025, 17,027,740 and 18,029,107 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Undivided profits | ||||||||||||||||||||
| Accumulated other comprehensive income, net of tax | ||||||||||||||||||||
| Treasury stock at cost - 3,090,769 and 2,089,402 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
